| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 38.088 | 5.628 | 8.159 | 12.345 | 1.444 | 191 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 38.670 | 5.641 | 8.162 | 12.561 | 1.444 | 191 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 19.707 | 4.752 | 5.824 | 7.094 | 1.701 | 354 | -620 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 18.963 | 889 | 2.338 | 5.467 | -257 | -163 | 620 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 17.803 | 720 | 2.093 | 5.090 | -301 | -168 | 620 | 0 | 0 | 0 |
| Employees | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - D & C Med Com S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 96.809 | 9.702 | 11.673 | 13.090 | 429 | 220 | 215 | 216 | 215 | 214 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 9.162 | 5.166 | 1.169 | 4.435 | 338 | 145 | 100 | 101 | 100 | 100 |
| Cash | 87.647 | 4.536 | 10.504 | 8.655 | 91 | 76 | 115 | 115 | 115 | 114 |
| Shareholders Funds | 76.297 | 8.978 | 10.919 | 5.142 | -250 | -414 | 215 | 216 | 215 | 214 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.512 | 724 | 754 | 7.948 | 679 | 634 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - D & C Med Com S.r.l.